Autumn is here, and we’ve squirrelled away some great acorns that have fallen from the mighty Drug Channels oak trees:
- Gilead’s new pricing starts to pop the gross-to-net bubble
- New fact-based insights on patient out-of-pocket costs and prescription abandonment
- Cool new stats on hospital-physician vertical integration by specialty
- The U.S. healthcare crisis will probably never end (Sorry.)
Plus, your friendly neighborhood blogger joins the board of 88.5 WXPN, the country’s leading non-commercial Triple A (adult, album, alternative) radio station.
P.S. Follow my daily stream of links to neat stuff at @DrugChannels on Twitter.Recent tweets have highlighted rebates, step therapy, PSAOs, white bagging, PBM network spreads, lab-based microbreweries, and more.
Read more »
Source: Post feed
